S. Oreña

发表

Expression transgenique de la glycogene synthase kinase 3 dans un muscle

R. Garofalo, J. Schachter, S. Oreña, 2002 .

Inhibition of Glycogen-synthase Kinase 3 Stimulates Glycogen Synthase and Glucose Transport by Distinct Mechanisms in 3T3-L1 Adipocytes*

R. Garofalo, S. Oreña, A. Torchia, 2000, The Journal of Biological Chemistry.

TNFalpha activation of PKCdelta, mediated by NFkappaB and ER stress, cross-talks with the insulin signaling cascade.

R. Garofalo, M. Greene, S. Oreña, 2010, Cellular signalling.

Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor.

S. Oreña, R. W. Stevenson, D. Kreutter, 1993, The American journal of physiology.

Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice.

H. Jaeschke, S. Zeisel, Swetha Rudraiah, 2015, Gastroenterology.

Extracts of Fruits and Vegetables Activate the Antioxidant Response Element in IMR-32 Cells.

S. Zeisel, N. Gillitt, F. Jin, 2015, The Journal of nutrition.

(3R,4S)-4-(2,4,5-Trifluorophenyl)-pyrrolidin-3-ylamine inhibitors of dipeptidyl peptidase IV: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.

Zhengrong Zhao, Dennis E Danley, M. Ammirati, 2007, Bioorganic & medicinal chemistry letters.

cis-2,5-dicyanopyrrolidine inhibitors of dipeptidyl peptidase IV: synthesis and in vitro, in vivo, and X-ray crystallographic characterization.

M. Ammirati, D. Danley, S. Wright, 2006, Journal of medicinal chemistry.

Suppression of insulin-stimulated glucose transport in L6 myocytes by calcitonin gene-related peptide.

S. Oreña, D. Kreutter, K. M. Andrews, 1989, Biochemical and biophysical research communications.

Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta.

J. Stock, J. Mcneish, K. Coleman, 2003, The Journal of clinical investigation.

Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass.

A. Swick, S. Oreña, annalouise O'Connor, 2013, Metabolism: clinical and experimental.

(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitor.

M. Ammirati, D. Danley, R. McPherson, 2009, Bioorganic & Medicinal Chemistry Letters.

Binding and uptake of copper from ceruloplasmin.

M. Linder, S. Oreña, C. Goode, 1986, Biochemical and biophysical research communications.

Extracts of Fruits and Vegetables Activate the Antioxidant Response Element in IMR-32 Cells.

S. Zeisel, N. Gillitt, S. Oreña, 2015, The Journal of nutrition.

(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitor.

M. Ammirati, D. Danley, R. McPherson, 2009, Bioorganic & medicinal chemistry letters.